Table 3.
Surgical Management
| Variable | Study Group (N = 115) | No Postoperative COVID-19 (n = 109) | Postoperative COVID-19 (n = 6) | P Value |
|---|---|---|---|---|
| Time period | 65 early/ 50 late | 59 early/ 50 late | 6 early/ 0 late | .03 |
| Approach | .01 | |||
| Open surgery | 71 (62) | 70 (64) | 1 (17) | |
| VATS | 30 (26) | 28 (26) | 2 (33) | |
| RATS | 14 (12) | 11 (10) | 3 (50) | |
| Procedure | .20 | |||
| Wedge resection | 3 (3) | 2 (2) | 1 (17) | |
| Segmentectomy | 19 (17) | 19 (17) | 0 | |
| Lobectomy | 86 (74) | 81 (74) | 5 (83) | |
| Pneumonectomy | 7 (6) | 7 (6) | 0 | |
| Lymph node dissection | .10 | |||
| Sampling | 2 (2) | 1 (1) | 1 (17) | |
| Radical | 113 (98) | 108 (99) | 5 (83) | |
| Type of complications | ||||
| Prolonged air leak | 18 (16) | 17 (16) | 1 (17) | .99 |
| Bacteria pneumonia | 11 (10) | 11 (10) | 0 | .99 |
| Atrial fibrillation | 5 (4) | 5 (5) | 0 | .99 |
| DVT/PE | 2 (2) | 1 (1) | 1 (17) | .10 |
| Inferior laryngeal nerve palsy | 1 (1) | 0 | 1 (17) | .05 |
| NCI CTCAE 5.0 Classification | ||||
| Grade 1 | 21 (18) | 19 (17) | 2 (33) | .30 |
| Grade 2 | 28 (24) | 27 (25) | 1 (17) | .99 |
| Grade 3 | 8 (7) | 4 (4) | 4 (67) | .001 |
| Grade 4 | 1 (1) | 1 (1) | 0 | .99 |
| Grade 5 | 1 (1) | 1 (1) | 0 | .99 |
| Outcomes | ||||
| Chest tube duration, d | 3 (2-5) | 3 (2-5) | 3 (3-5) | .53 |
| Hospital length of stay, d | 7 (5-11) | 7 (5-10) | 5 (4-9) | .73 |
| Readmission | 8 (7) | 5 (5) | 3 (50) | .004 |
Values are presented as median (interquartile range) or n (%).
DVT/PE, deep venous thrombosis/pulmonary embolism; NCI CTCAE, National Cancer Institute Common Terminology Criteria for Adverse Events; RATS, robot assisted thoracic surgery; VATS, video assisted thoracic surgery.